Importantly, both WT-DLC1 and K714E-DLC1 were able to restore tumor growth from DLC1-KD A375 cells to a greater extent without altering RHOA activity (Supplementary Fig. 3b, c), further confirming the oncogenic role of nuclear DLC1 independent of RhoGAP. The gene discussed is DLC1; the disease is neoplasm.